Literature DB >> 18585034

Synthesis of macrocyclic trypanosomal cysteine protease inhibitors.

Yen Ting Chen1, Ricardo Lira, Elizabeth Hansell, James H McKerrow, William R Roush.   

Abstract

The importance of cysteine proteases in parasites, compounded with the lack of redundancy compared to their mammalian hosts makes proteases attractive targets for the development of new therapeutic agents. The binding mode of K11002 to cruzain, the major cysteine protease of Trypanosoma cruzi was used in the design of conformationally constrained inhibitors. Vinyl sulfone-containing macrocycles were synthesized via olefin ring-closing metathesis and evaluated against cruzain and the closely related cysteine protease, rhodesain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585034      PMCID: PMC2642929          DOI: 10.1016/j.bmcl.2008.06.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  22 in total

1.  A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi.

Authors:  S C Barr; K L Warner; B G Kornreic; J Piscitelli; A Wolfe; L Benet; J H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 2.  Progresses in the field of drug design to combat tropical protozoan parasitic diseases.

Authors:  Guadalupe E García Liñares; Esteban L Ravaschino; Juan B Rodriguez
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 3.  Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).

Authors:  José A Castro; Maria Montalto de Mecca; Laura C Bartel
Journal:  Hum Exp Toxicol       Date:  2006-08       Impact factor: 2.903

Review 4.  The proteases and pathogenicity of parasitic protozoa.

Authors:  J H McKerrow; E Sun; P J Rosenthal; J Bouvier
Journal:  Annu Rev Microbiol       Date:  1993       Impact factor: 15.500

5.  Vinyl sulfones as mechanism-based cysteine protease inhibitors.

Authors:  J T Palmer; D Rasnick; J L Klaus; D Brömme
Journal:  J Med Chem       Date:  1995-08-18       Impact factor: 7.446

6.  Synthesis of acyclic and dehydroaspartic acid analogues of Ac-Asp-Glu-OH and their inhibition of rat brain N-acetylated alpha-linked acidic dipeptidase (NAALA dipeptidase).

Authors:  N Subasinghe; M Schulte; M Y Chan; R J Roon; J F Koerner; R L Johnson
Journal:  J Med Chem       Date:  1990-10       Impact factor: 7.446

7.  Structure-activity relationships for inhibition of papain by peptide Michael acceptors.

Authors:  S Liu; R P Hanzlik
Journal:  J Med Chem       Date:  1992-03-20       Impact factor: 7.446

8.  Structure-based design and synthesis of macroheterocyclic peptidomimetic inhibitors of the aspartic protease beta-site amyloid precursor protein cleaving enzyme (BACE).

Authors:  Stephen Hanessian; Gaoqiang Yang; Jean-Michel Rondeau; Ulf Neumann; Claudia Betschart; Marina Tintelnot-Blomley
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

9.  The crystal structure of cruzain: a therapeutic target for Chagas' disease.

Authors:  M E McGrath; A E Eakin; J C Engel; J H McKerrow; C S Craik; R J Fletterick
Journal:  J Mol Biol       Date:  1995-03-24       Impact factor: 5.469

10.  Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection.

Authors:  J C Engel; P S Doyle; I Hsieh; J H McKerrow
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

View more
  7 in total

1.  Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.

Authors:  Natacha Cerny; Andrés Sánchez Alberti; Augusto E Bivona; Mauricio C De Marzi; Fernanda M Frank; Silvia I Cazorla; Emilio L Malchiodi
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

2.  Two approaches to discovering and developing new drugs for Chagas disease.

Authors:  J H McKerrow; P S Doyle; J C Engel; L M Podust; S A Robertson; R Ferreira; T Saxton; M Arkin; I D Kerr; L S Brinen; C S Craik
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

3.  Benzimidazole inhibitors of the major cysteine protease of Trypanosoma brucei.

Authors:  Glaécia An Pereira; Lucianna H Santos; Steven C Wang; Luan C Martins; Filipe S Villela; Weiting Liao; Marco A Dessoy; Luiz C Dias; Adriano D Andricopulo; Mariana Af Costa; Ronaldo Ap Nagem; Conor R Caffrey; Klaus R Liedl; Ernesto R Caffarena; Rafaela S Ferreira
Journal:  Future Med Chem       Date:  2019-07       Impact factor: 3.808

4.  Vinyl sulfones as antiparasitic agents and a structural basis for drug design.

Authors:  Iain D Kerr; Ji H Lee; Christopher J Farady; Rachael Marion; Mathias Rickert; Mohammed Sajid; Kailash C Pandey; Conor R Caffrey; Jennifer Legac; Elizabeth Hansell; James H McKerrow; Charles S Craik; Philip J Rosenthal; Linda S Brinen
Journal:  J Biol Chem       Date:  2009-07-20       Impact factor: 5.157

5.  Chloroaluminate Ionic Liquid Immobilized on Magnetic Nanoparticles as a Heterogeneous Lewis Acidic Catalyst for the Friedel-Crafts Sulfonylation of Aromatic Compounds.

Authors:  Ngoc-Lan Thi Nguyen; Quoc-Anh Nguyen; Tien Khoa Le; Thi Xuan Thi Luu; Kim-Ngan Thi Tran; Phuoc-Bao Pham
Journal:  Molecules       Date:  2022-03-02       Impact factor: 4.411

6.  Chemical-biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target.

Authors:  Jonathan W Choy; Clifford Bryant; Claudia M Calvet; Patricia S Doyle; Shamila S Gunatilleke; Siegfried S F Leung; Kenny K H Ang; Steven Chen; Jiri Gut; Juan A Oses-Prieto; Jonathan B Johnston; Michelle R Arkin; Alma L Burlingame; Jack Taunton; Matthew P Jacobson; James M McKerrow; Larissa M Podust; Adam R Renslo
Journal:  Beilstein J Org Chem       Date:  2013-01-04       Impact factor: 2.883

7.  In vitro and in vivo trypanocidal activity of H2bdtc-loaded solid lipid nanoparticles.

Authors:  Zumira A Carneiro; Pedro I da S Maia; Renata Sesti-Costa; Carla D Lopes; Tatiana A Pereira; Cristiane M Milanezi; Marcelo A Pereira da Silva; Renata F V Lopez; João S Silva; Victor M Deflon
Journal:  PLoS Negl Trop Dis       Date:  2014-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.